Health

Business Wire Australia and New Zealand

Public Health Leaders Urge FDA to Issue Final Rule for Reducing Nicotine in Cigarettes by March 2019

25-May-2018 9:16 AM
22nd Century’s VLNTM tobacco makes possible the FDA’s plan to render all cigarettes sold in the US minimally or non-addictive. CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechn

Business Wire Australia and New Zealand

Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease

23-May-2018 6:19 PM
Data presented at American Thoracic Society meeting underpin the benefits of Spiolto® Respimat® for physical activity in COPD1,2 Study published in American Journal of Respiratory and Critical Care Medicine shows Spiolto®

Business Wire Australia and New Zealand

Zephyr Endobronchial Valves Improve Breathing, Quality of Life and Activity for Severe Emphysema Patients in US Pivotal Trial

23-May-2018 9:23 AM
Study Met All Primary and Secondary Endpoints Across Multiple Measures of Breathing and Quality of Life One Year After Treatment   Zephyr Endobronchial Valves (Photo: Business Wire) SAN DIEGO & REDWOOD CITY, Calif.--(B

Business Wire Australia and New Zealand

ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy

23-May-2018 9:11 AM
Data from more than 2.6 million sleep apnea patients reveals 75 percent adherence rate when patients are remotely monitored Separate study shows enrolling in resupply programs increases long-term device usage, and decreases termination r

Business Wire Australia and New Zealand

Efficacy and safety of OFEV® reinforced in new presentations at ATS 2018

22-May-2018 5:34 PM
New analysis of the INPULSIS® and TOMORROW trials suggests treatment with OFEV® (nintedanib) associated with reduced risk of death in patients with idiopathic pulmonary fibrosis Separate analysis of INPULSIS® trials showed ass

Business Wire Australia and New Zealand

AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model

22-May-2018 11:26 AM
Presentation describes development and corroboration of health economic model that has demonstrated cost savings associated with the use of the RECELL® Device   VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical

Business Wire Australia and New Zealand

Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate

22-May-2018 9:03 AM
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects   Woman wearing CPAP, the gold standard treatment for sleep apnea

Business Wire Australia and New Zealand

Janssen Announces European Commission Approval of JULUCA® (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1

22-May-2018 8:42 AM
Dolutegravir/rilpivirine, the result of a collaboration with ViiV Healthcare, offers a complete daily treatment regimen for virologically suppressed adults living with HIV-1 in a single-pill CORK, Ireland--(BUSINESS WIRE)--The Ja

Business Wire Australia and New Zealand

ResMed-sponsored Studies Show Combining Home Oxygen and Home Non-invasive Ventilation is a Cost Effective Treatment for COPD

21-May-2018 8:33 AM
Studies presented at the ATS 2018 International Conference demonstrate that combining home non-invasive ventilation with home oxygen therapy is more cost effective for patients with COPD and reduces risks of mortality and hospital readm

Business Wire Australia and New Zealand

Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings

18-May-2018 9:35 AM
– Data Being Presented Underscore Commitment to Improving Patient Outcomes and Care – – Six Takeda Oncology-Sponsored Abstracts Accepted for Presentation at ASCO 2018 and Eight Abstracts Accepted for Presentation at EHA 2018 –

Business Wire Australia and New Zealand

Pierre Fabre and Array BioPharma Announce COLUMBUS Phase 3 Study Overall Survival Results in BRAF-Mutant Melanoma Will Be Presented at 2018 ASCO Annual Meeting

18-May-2018 9:03 AM
  - Pierre Fabre with its partner Array BioPharma will be presenting data from the pivotal Phase 3 COLUMBUS trial in patients with BRAF-mutant melanoma on June 4 CASTRES, France--(BUSINESS WIRE)--Pierre Fabre with its partner A

Business Wire Australia and New Zealand

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer

17-May-2018 2:40 PM
  58% Fewer patients proceed to Biopsy US Rollout well advanced SYDNEY--(BUSINESS WIRE)--Australian immuno-oncology company Minomic International Ltd is pleased to announce the completion of its prospective clinical trial of the com

Business Wire Australia and New Zealand

2018 International Symposium on Human Identification Keynote Announced: Andrew Hessel, The Golden Age of Genomics

16-May-2018 10:46 AM
MADISON, Wis.--(BUSINESS WIRE)--Explore the latest developments in forensic DNA research, process and techniques alongside scientists, law enforcement professionals and forensic experts from around the world at the 29th Internatio

Business Wire Australia and New Zealand

Cerveau Technologies, Inc. Signs Research Agreement with Tokyo Metropolitan Institute of Gerontology, Japan

16-May-2018 10:41 AM
  BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with the Tokyo Metropolitan Institute of Gerontology in Japan to support multiple projects over the next several years. These research projects are fo

Business Wire Australia and New Zealand

Anatara Announces Exclusive Global License Agreement with Zoetis

15-May-2018 12:30 PM
  Key points: Anatara has signed an exclusive agreement with Zoetis Inc., the leading global animal health company, to license Detach® - Anatara’s non-antibiotic approach to aid in the control of diarrhoeal disease in live

Business Wire Australia and New Zealand

International Food & Beverage Companies Support the Call by the World Health Organization and Resolve to Save Lives for the Elimination of Industrially Produced Trans Fat from the Global Food Supply

15-May-2018 8:39 AM
GENEVA--(BUSINESS WIRE)--The International Food & Beverage Alliance (IFBA) today announced its support for the call by the World Health Organization and non-governmental organization, Resolve to Save Lives, for the elimination of indust

Business Wire Australia and New Zealand

New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions

14-May-2018 4:35 PM
MADRID--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers evaluated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in reducing the number of unnecessar

Business Wire Australia and New Zealand

Takeda Reports FY2017 Full Year Results and Issues FY2018 Guidance

14-May-2018 4:31 PM
FY2017 performance reflects superior execution Underlying results: Revenue +5.5%, Core Earnings +40.2%, Core EPS +44.8% Takeda will maintain its underlying growth momentum in FY2018   OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutica

Business Wire Australia and New Zealand

ResMed’s New QuietAir Diffuser Vent for CPAP Masks Reduces Noise by 89 Percent

11-May-2018 8:49 AM
QuietAir also produces a 70 percent gentler exhaled airflow ResMed QuietAir diffuser vent elbow (Photo: Business Wire) SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its

Business Wire Australia and New Zealand

The Australian and New Zealand College of Anaesthetists Joins the Patient Safety Movement Foundation as a Committed Partner to Eliminate Preventable Harm in Hospitals

10-May-2018 9:02 AM
Dr. Michael A. E. Ramsay, Patient Safety Movement Board Member, (left) and ANZCA President, Professor David A. Scott (right), sign ANZCA’s Commitment to Action Letter (Photo: Business Wire) SYDNEY--(BUSINESS WIRE)--The Australian and New Z